Navigation Links
Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery
Date:10/1/2007

BRIDGEWATER, N.J., Oct. 1 /PRNewswire-FirstCall/ -- Sanofi-aventis announced that the U.S. Food and Drug Administration (FDA) has approved Taxotere(R) (docetaxel) Injection Concentrate in combination with cisplatin and 5-fluorouracil for induction therapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN) before patients undergo chemoradiotherapy and surgery.

The FDA based its approval on the results of the phase III randomized, open-label, international trial, TAX 324, which established the efficacy and safety of the Taxotere-based regimen in significantly improving survival.

Approval Based on Clinical Trial Tax 324

Among patients treated with Taxotere-based therapy (TPF, n=251) overall survival was significantly improved compared to patients receiving just cisplatin and 5-fluorouracil (PF, n=243); the relative risk of death was 30% lower (HR 0.70; p=0.0058). Patients treated with TPF had a longer median overall survival of 70.6 months vs. 30.1 months for patients receiving PF only, representing a more than three year improvement in median OS for patients treated with TPF. The probability to survive three years was 62% in the TPF arm compared to 48% in the PF arm.

"The TAX 324 trial found that the addition of Taxotere to standard induction chemotherapy significantly improved patient survival, adding years to patients' lives," noted clinical investigator Marshall Posner, MD, Medical Director of the Head and Neck Oncology Program at Dana-Farber Cancer Institute in Boston. "The approval of Taxotere to be given in combination with other standard chemotherapy as the first step in a therapeutic sequence followed by chemoradiotherapy and surgery is a significant advancement in treatment for patients with locally advanced head and neck cancer."

All patients entering TAX 324 had tumors of the oropharynx, larynx, hypopharynx or oral cavity that either could not be removed, were considered potentially operable but unl
'/>"/>

SOURCE sanofi-aventis
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
2. Allos Therapeutics PDX Granted Orphan Medicinal Product Designation by the European Commission
3. Pixantrone Granted Fast Track Designation by FDA for Relapsed Indolent NHL Patients
4. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
5. Point of Care Strep Tests Speed Treatment, Lower Costs
6. Rapid HIV Testing Increases Possibility of Treatment
7. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
8. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014  In part ... to leverage a hospital pharmacy as a strategic asset, ... national practice leader for Cardinal Health,s Innovation Delivery Solutions ... care can benefit both hospitals and patients. ... only one part of their job in a value-based ...
(Date:8/29/2014)... Pixcelldata, the innovative Irish developer ... a major new deal with Dutch based eX-Path, global ... Dr. Marius Nap . The announcement ... of Pathology which is taking placing between August 30th ... London where Pixcelldata will demonstrate its innovative ...
(Date:8/28/2014)... NEW YORK, Aug. 28, 2014 Reportlinker.com ... available in its catalogue: North America ... 2020 http://www.reportlinker.com/p02343466/North-America-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html ... Market Outlook to 2020 Summary GlobalData,s ... Devices Market Outlook to 2020", provides key market ...
Breaking Medicine Technology:Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4Pixcelldata Announces New Deal with Dutch Tele-Pathology Specialists eX-Path Ahead of ECP 2014 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 4North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 6North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 7North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 8North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 9North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 10North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 11North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 12North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 13North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 14North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 15North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 16
(Date:8/31/2014)... MD (PRWEB) August 31, 2014 ... health records (EHR) software firm that focuses on ... practice success found a congruent commitment with the ... Sports . , “We create an environment that ... effortlessly, allowing more time with patients,” says Steven ...
(Date:8/31/2014)... This September, California Library Literacy ... celebrates 30 years of changing the lives of ... California’s Library Literacy Services has helped nearly a ... and write. , To mark the 30th anniversary ... launching a month-long awareness campaign titled “Together, California ...
(Date:8/31/2014)... Sunday 31 August 2014: Wine only protects against ... results from the In Vino Veritas (IVV) study presented ... the Czech Republic. , Professor Taborsky said: "This is ... and white wine on markers of atherosclerosis (1) in ... found that moderate wine drinking was only protective in ...
(Date:8/30/2014)... August 2014: A retrievable and repositionable transcatheter aortic ... world setting, according to research presented at ESC ... Germany. The direct flow medical (DFM) transcatheter aortic ... and has the potential to improve transcatheter aortic ... aortic stenosis. , Dr Pyxaras said: "TAVI is ...
(Date:8/30/2014)... Malden, MA (PRWEB) August 31, 2014 In ... ‘dog eat dog’ approach, Karma Web Group, LLC launches a ... iOS and Android the newly launched Ultimate Karma app is ... rewarded with new levels of play, the game pulls double-duty ... at the same time. , Designed to reward gamers for ...
Breaking Medicine News(10 mins):Health News:Powerhouse EHR, Future Health, Announces Gold Sponsorship of POWERPlay in Sports National Tour 2Health News:Powerhouse EHR, Future Health, Announces Gold Sponsorship of POWERPlay in Sports National Tour 3Health News:Powerhouse EHR, Future Health, Announces Gold Sponsorship of POWERPlay in Sports National Tour 4Health News:California Library Literacy Services Celebrates 30th Anniversary 2Health News:California Library Literacy Services Celebrates 30th Anniversary 3Health News:Wine only protects against CVD in people who exercise 2Health News:Retrievable transcatheter aortic valve effective and safe in real world setting 2Health News:Newly Launched Ultimate Karma App Elicits Happiness in Players and Encourages Moral Values 2
... , ... Plastic Surgeon Dr. Michael R. Macdonald announced the launch of a new plastic surgery ... plastic surgery patients who chronicle their cosmetic surgery experience through detailed daily accounts of ... ...
... safe amount of alcohol for women during this time, experts ... may have another reason to avoid drinking, with a new ... for a rare blood cancer in children. , The research, ... leukemia (AML), an often fatal blood cancer, increased by 56 ...
... choice when evaluating patients with foot drop (an inability or ... of the foot while taking a step), according to a ... in San Diego, CA. Ultrasound imaging is non-invasive and involves ... produce pictures of inside the body. Foot drop is ...
... As Drinking ... in encouraging everyone to play a role in keeping our water supplies and systems secure. ... Denver, CO (Vocus) ... (AWWA) joins water professionals across North America in encouraging everyone to play a role in ...
... ... , ... May 6, 2010 -- Phybridge Inc , a leading provider of IP telephony ... the Cool Vendors in Enterprise Communications Applications, 2010 report published March 31, 2010 by ...
... ... set…GO! Summer kicks off each year with the City of Laguna ... year, the event is expected to bring out more than 6,000 runners, ... Day – Monday May 31. Registration is available online at www.lagunahillshalfmarathon.com ...
Cached Medicine News:Health News:San Francisco Plastic Surgeon Releases Plastic Surgery Patient Recovery Blog 2Health News:Drinking While Pregnant Tied to Rare Leukemia in Offspring 2Health News:Drinking While Pregnant Tied to Rare Leukemia in Offspring 3Health News:Water Community Stresses Importance of Security During Drinking Water Week 2Health News:Phybridge Named "Cool Vendor" by Leading Analyst Firm 2Health News:City of Laguna Hills Announces Memorial Day Half Marathon and 5K 2
... Monitor (PCM) and Central Station provide an ... extends the cardiac cath or electrophysiology lab ... and/or EP procedures, providing both physiomonitoring parameters ... either standalone or on its own network. ...
For the critical care environment, telemetry, emergency room and other monitoring areas....
DS 7600 Central Station...
... Gemini Family of infusion pumps ... a collective series of administration ... line offers a wide variety ... sets, each featuring the patented ...
Medicine Products: